Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
2024 · Gut Microbes · 108 citations
https://doi.org/10.1080/19490976.2024.2307568
H
Haripriya Gupta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
1.5K
Citations
22
h-index
29
i10-index
Haripriya Gupta is an academic researcher from Hallym University Medical Center. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Gut microbiota and health & Diet and metabolism studies. The author has an h-index of 22, co-authored 52 publications.
ORCID: 0000-0002-6008-1143Papers by this author
worksBifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
2023 · Frontiers in Microbiology · 70 citations
https://doi.org/10.3389/fmicb.2023.1129904
The identification of metabolites from gut microbiota in NAFLD via network pharmacology
2023 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-023-27885-w
The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22709529
New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24132711
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat